Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Sucralfate causes malabsorption of L-thyroxine

S I Sherman1, E T Tielens, P W Ladenson

  • 1Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.

The American Journal of Medicine
|June 1, 1994
PubMed
Summary

Sucralfate significantly reduces the absorption of L-thyroxine when taken together, potentially impacting thyroid hormone replacement therapy. Separating doses by 8 hours prevents this malabsorption.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Safety and activity of vandetanib in combination with everolimus in patients with advanced solid tumors: a phase I study.

ESMO open·2021
Same author

No calcitonin change in a person taking dulaglutide diagnosed with pre-existing medullary thyroid cancer.

Diabetic medicine : a journal of the British Diabetic Association·2017
Same author

Risk of Thyroid Cancer Among Solid Organ Transplant Recipients.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2017
Same author

The impact of age and gender on papillary thyroid cancer survival.

The Journal of clinical endocrinology and metabolism·2012
Same author

Approach to the patient with advanced differentiated thyroid cancer.

European journal of endocrinology·2011
Same author

Cytotoxic chemotherapy for differentiated thyroid carcinoma.

Clinical oncology (Royal College of Radiologists (Great Britain))·2010

Area of Science:

  • Endocrinology
  • Pharmacokinetics
  • Gastroenterology

Background:

  • Levothyroxine (L-thyroxine) is a critical medication for treating hypothyroidism.
  • Sucralfate is a medication used to treat ulcers and gastrointestinal irritation.

Observation:

  • Simultaneous administration of sucralfate with L-thyroxine markedly reduced L-thyroxine absorption by approximately 72%.
  • This malabsorption effect was mitigated when sucralfate and L-thyroxine doses were separated by 8 hours.
  • Co-administration of sucralfate also appeared to reduce the suppressive effect of L-thyroxine on thyroid-stimulating hormone (TSH).

Findings:

  • Sucralfate causes significant malabsorption of orally administered L-thyroxine.
  • The mechanism is likely due to intraluminal binding of the hormone by sucralfate.
  • Timing of administration is crucial; separating doses prevents impaired absorption.

Implications:

  • Patients taking L-thyroxine should avoid concurrent administration with sucralfate.
  • Healthcare providers should advise patients on optimal dosing intervals to ensure therapeutic efficacy of L-thyroxine.
  • Further research may explore alternative binding agents or modified formulations to minimize drug interactions.

Related Experiment Videos